Clinical Investigation on the Use of Ophthalmic Solution Based on Sodium Hyaluronate in Treatment of Eye Discomfort
NCT05777798 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28
Last updated 2026-01-07
Summary
The purpose of this study is to assess the performance and safety resulting from the treatment of an ophthalmic solution for the ocular discomfort and in particular in presence of ocular dryness.
Conditions
- Ocular Dryness
Interventions
- DEVICE
-
Hyalistil Bio PF
Moisturizing and lubricating ophthalmic solution
Sponsors & Collaborators
-
SIFI SpA
lead INDUSTRY
Principal Investigators
-
Davide Scollo, M.D. · U.O.S. Oculistica "San Marco" A.O.U. Policlinico "G.Rodolico-San Marco" Catania, Italy
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-14
- Primary Completion
- 2023-08-03
- Completion
- 2023-08-03
Countries
- Italy
Study Locations
More Related Trials
-
A Phase II, Dose Ranging Study Of CP-690,550 Eye Drops In Patients With Dry Eye Disease
NCT01135511 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Performance and Safety of Eye Drops With Hyaluronic Acid 0.30% and 0.15%
NCT06189456 ·Status: RECRUITING ·Phase: NA
-
PMCF Study to Evaluate Performance and Safety of "HPMC-based Eyedrops" Used to Relieve Dry Eye Symptoms
NCT05825599 ·Status: COMPLETED ·Phase: NA
-
Cross-linked Hyaluronic Acid and Coenzyme Q10 in the Treatment of Dry Eye
NCT03074344 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of Cyclosporine Ophthalmic Emulsion in Patients With Dry Eye Disease
NCT00717418 ·Status: COMPLETED
-
A Study for Evaluation of the Efficacy and Safety of SI-614 Ophthalmic Solution in Patient With Dry Eye
NCT05411367 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers
NCT00335114 ·Status: COMPLETED ·Phase: NA
-
Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome
NCT01382225 ·Status: COMPLETED ·Phase: PHASE3
-
Exploratory Study of OPC-12759 Ophthalmic Suspension
NCT01493180 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye
NCT01558999 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-response Study of OPC-12759 Ophthalmic Suspension
NCT00234078 ·Status: COMPLETED ·Phase: PHASE2
-
Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01101984 ·Status: COMPLETED ·Phase: NA
-
Trial of CF101 to Treat Patients With Dry Eye Disease
NCT01235234 ·Status: COMPLETED ·Phase: PHASE3
-
PMCF Study to Evaluate Performance and Safety of "Distilled Waters-based Eyedrops" Used to Relieve Dry Eye Symptoms
NCT05825586 ·Status: COMPLETED ·Phase: NA
-
Study of SkQ1 as Treatment for Dry-eye Syndrome
NCT03764735 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-Center Study Subjects With Dry Eye Syndrome
NCT01745887 ·Status: COMPLETED ·Phase: PHASE1
-
Confirmatory Study of OPC-12759 Ophthalmic Suspension
NCT00885079 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Preservative-free Low-dose Hyaluronic Acid-containing Salt Solution on Dry Eye Disease
NCT03888183 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of the Effect of Zinc-Hyaluronate on Ocular Surface Sensations in Patients With Dry Eye
NCT02951910 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Different Hyaluronic Acid Tear Substitutes Formulations in Evaporative Dry Eye
NCT06517667 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Hydroxypropyl-methylcellulose and GlicoPro® Eyedrops in the Treatment of Dry Eye Disease: Clinical Study
NCT06726525 ·Status: COMPLETED ·Phase: PHASE4
-
Phase III Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01240382 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
NCT02004067 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Tolerability and Pharmacokinetics of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunteers (Phase I)
NCT01476332 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Pilocarpine As a Secretagogue Versus Artificial Tears for the Treatment of Dry Eye
NCT06752278 ·Status: COMPLETED ·Phase: NA